Works matching IS 11732563 AND DT 2023 AND VI 43 AND IP 10
Results: 6
Effectiveness of Dupilumab for Chronic Prurigo in Chinese Patients: A Real-World Case Series Study.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 10, p. 799, doi. 10.1007/s40261-023-01307-1
- By:
- Publication type:
- Article
Effectiveness and Safety of Remdesivir in Treating Hospitalised Patients with COVID-19: A Propensity Score Analysis of Real-Life Data from a Monocentric Observational Study in Times of Health Emergency.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 10, p. 763, doi. 10.1007/s40261-023-01304-4
- By:
- Publication type:
- Article
A Phase 1 Study of Ensitrelvir Fumaric Acid Tablets Evaluating the Safety, Pharmacokinetics and Food Effect in Healthy Adult Populations.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 10, p. 785, doi. 10.1007/s40261-023-01309-z
- By:
- Publication type:
- Article
Tumor Lysis Syndrome with CD20 Monoclonal Antibodies for Chronic Lymphocytic Leukemia: Signals from the FDA Adverse Event Reporting System.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 10, p. 773, doi. 10.1007/s40261-023-01308-0
- By:
- Publication type:
- Article
Safety of Interleukin Inhibitors in Patients with Plaque Psoriasis and Neoplasm: A Retrospective Study from Two Referral Centers.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 10, p. 807, doi. 10.1007/s40261-023-01306-2
- By:
- Publication type:
- Article
Acthar<sup>®</sup> Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 10, p. 739, doi. 10.1007/s40261-023-01303-5
- By:
- Publication type:
- Article